A Review on Recent Orphan Drugs
Keywords:
Orphan drugs, Orphan/rare diseases, Neglected disease, Orphan drug actAbstract
The drugs or biological products for the diagnosis, treatment, or, prevention of a rare disease or condition are orphan drugs. Even though the drugs intended to treat common disease where revenue is not expected by pharmaceutical manufacturer are as well categorized as orphan. United State of America (USA) was the first nation to propose a legal framework to encourage development and availability of orphan drugs. The orphan drug act was passed on January 28, 1983 by U.S.A.to stimulate the research, development, and approval of those products that treat orphan diseases. The regulation for orphan drugs varies in different countries. Orphan diseases are a spectrum of medical conditions with very different etiologies, the common denominator being the infrequency of their occurrence in the population. The new business model of orphan drugs could offer an integrated healthcare solution that enables pharmaceutical companies to develop newer areas of therapeutics, diagnosis, treatment, monitoring, and patient support. Incentives for drug development provided by governments, as well as support from the FDA and national organizations in special protocols are a further boost for the companies developing orphan drugs. Although there may still be challenges ahead for the pharmaceutical industry, orphan drugs seem to offer the key to recovery and stability within the market
Downloads
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).